The in vitro and in vivo anti-tumor effects of JS']JS-K in MM

被引：0
|
作者：
Kiziltepe, T.
Hideshima, T.
Raje, N.
Ishitsuka, K.
Ocio, E. M.
Catley, L.
Li, C. Q.
Trudel, L.
Yasui, H.
Shirashi, N.
Tai, Y. T.
Chauhan, D.
Mitsiades, C.
Saavedra, J. E.
Wong, G. N.
Keefer, L. K.
Shami, P. J.
Anderson, K. C.
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[2] Harvard Univ, MIT, Biol Engn Div, Cambridge, MA 02139 USA
[3] SAIC, Frederick, MD USA
[4] NCI, NIH, Comparat Carcinogenesis Lab, Frederick, MD 21701 USA
[5] Univ Utah, Dept Med Oncol, Salt Lake City, UT 84112 USA
[6] Salt Lake City Vet Adm Med Ctr, Salt Lake City, UT USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [1] JS']JS-K: Pathways of anticancer action
    Basudhar, Debashree
    Ridnour, Lisa A.
    Miranda, Katrina M.
    Wink, David A.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 577 - 577
  • [2] JS']JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo
    Kiziltepe, Tanyel
    Anderson, Kenneth C.
    Kutok, Jeffery L.
    Jia, Lee
    Boucher, Kenneth M.
    Saavedra, Joseph E.
    Keefer, Larry K.
    Shami, Paul J.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (01) : 145 - 151
  • [3] Synthesis and in vitro anti-leukemic activity analogues of JS']JS-K, an anti-cancer lead of structural compound
    Chakrapani, Harinath
    Goodblatt, Michael M.
    Udupi, Vidya
    Malaviya, Swati
    Shami, Paul J.
    Keefer, Larry K.
    Saavedra, Joseph E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 950 - 953
  • [4] Synthesis and evaluation of piperazine and homopiperazine analogues of JS']JS-K, an anti-cancer lead compound
    Nandurdikar, Rahul S.
    Maciag, Anna E.
    Citro, Michael L.
    Shami, Paul J.
    Keefer, Larry K.
    Saavedra, Joseph E.
    Chakrapani, Harinath
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2760 - 2762
  • [5] JS']JS-K, a novel nitric oxide (NO) generator, shows potent anti-angiogenic activity.
    Shami, PJ
    Kaur, G
    Thillainathan, J
    Jia, L
    Saavedra, JE
    Keefer, LK
    [J]. BLOOD, 2004, 104 (11) : 931A - 931A
  • [6] Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS']JS-K in murine erythroleukemia cells
    Kaczmarek, Monika Z.
    Holland, Ryan J.
    Lavanier, Stephen A.
    Troxler, Jami A.
    Fesenkova, Valentyna I.
    Hanson, Charlotte A.
    Cmarik, Joan L.
    Saavedra, Joseph E.
    Keefer, Larry K.
    Ruscetti, Sandra K.
    [J]. LEUKEMIA RESEARCH, 2014, 38 (03) : 377 - 382
  • [7] Synergy studies between the nitric oxide (NO) donor JS']JS-K and other anti-leukemic agents.
    Shami, Paul J.
    Eddington, Jordan K.
    Udupi, Vidya
    Kosak, Ken M.
    Saavedra, Joseph E.
    Keefer, Larry K.
    [J]. BLOOD, 2006, 108 (11) : 177B - 177B
  • [8] JS']JS-K as a broad-spectrum anticancer agent: Lead optimization strategies
    Keefer, Larry K.
    Maciag, Anna E.
    Holland, Ryan J.
    Saavedra, Joseph E.
    Ji, Xinhua
    Kumari, Vandana
    Kim, Youseung
    Shami, Paul J.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [9] A review of the relatively complex mechanism of JS']JS-K induced apoptosis in cancer cells
    Tan, Guobin
    Wu, Aiming
    Li, Zhiqin
    Awasthi, Prashant
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1602 - 1608
  • [10] Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS']JS-K
    Sjodin, Birgitta
    Mannervik, Bengt
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
12345